Global Desmopressin Market, By Form (Injectable Solution, Nasal Spray, Tablet), Applications (Paediatric Use and Geriatric Use), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Desmopressin Market Analysis and Size
Desmopressin is used to treat a wide variety of medical conditions, which includes nocturnal polyuria, diabetes insipidus, hemophilia A, Willebrand disease, uremic bleeding. The increasing incidence of diabetes insipidus among people and the surge in bedwetting episodes in children have created a successful market for desmopressin acetate globally. Manufacturers in the desmopressin acetate are projected to improve their regional product footprint along with numerous promotional activities such as awareness programs about the measures to prevent nighttime bedwetting, treatment of diabetes insipidus.
Data Bridge Market Research analyses a growth rate in the desmopressin market in the forecast period 2023-2030. The expected CAGR of desmopressin market is tend to be around 5.8% in the mentioned forecast period. The market was valued at USD 1055.63 million in 2022, and it would grow upto USD 1657.28 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Desmopressin Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Form (Injectable Solution, Nasal Spray, Tablet), Applications (Paediatric Use and Geriatric Use), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), Teva Pharmaceutical Industries Ltd (Israel), NorthStar Rx LLC (U.S.), Sun Pharmaceutical Industries Ltd. (India), avenit software shanghai ltd (China), Ferring B.V. (Switzerland), Amring Pharmaceuticals Inc. (U.S.), Apotex Inc (Canada), Glenmark Pharmaceuticals Ltd (India), Mylan N.V. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Desmopressin is a type of vasopressin and is widely used to replace a low level of vasopressin. The desmopressin medication aids in controlling the rising urge of urination and dehydration. It has also been used to control night-time bedwetting in children. Furthermore, in conditions such as diabetes insipidus, wherein the body produces an abnormally large amount of urine, desmopressin medicines have been used widely.
Desmopressin Market Dynamics
Drivers
- Growing Prevalence of Diabetes
The number of people suffering from diabetes rise from 108 million in 1980 to 422 million in 2014. Prevalence has increased rapidly in low and middle-income countries compared to high-income countries. Between 2000 and 2019, there was a 3% increase in diabetes mortality rates by age. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths. Numerous studies have shown that zinc improves glucose levels in people suffering from diabetes. This leads to the market growth.
- Increased Awareness About the Diseased Conditions
The developing research associated with the market increases the expansion rate during the forecast period. The more adoption of clinical drugs for this diseased condition will bring much favourable outcomes. Furthermore, the treatment involves both counseling sessions and drugs. Therefore, the market tends to grow at a fast pace considering both the options.
Opportunities
- Increasing Investments by Several market Players
There have been rising investments by multiple market players that are helping boost the market's growth. For instance, in September 2017, Amring Pharmaceuticals announced its plans to invest in desmopressin acetate to meet its commitment of providing high-quality generic medicines and excellent customer service at a reasonable price.
Restraints/Challenges
- Side-Effects of Antipsychotic Drugs
Desmopressin can show major complications. Heavy dosage of this drug can cause flushing, nausea, transient headache, and mild abdominal cramps. This hampers the market growth.
This desmopressin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the desmopressin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Desmopressin Market Scope
The desmopressin market is segmented on the basis of form, applications, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Form
- Injectable Solution
- Nasal Spray
- Tablet
Applications
- Paediatric Use
- Geriatric Use
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Desmopressin Market Regional Analysis/Insights
The desmopressin market is analyzed and market size insights and trends are provided by form, applications, distribution channel and end-user as referenced above.
The major countries covered in the desmopressin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific will expect the highest growth for the desmopressin market throughout the forecasted period due to increased new research and developments on the desmopressin market.
North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Desmopressin Market Share Analysis
The desmopressin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to desmopressin market.
Key players operating in the desmopressin market include:
- Pfizer Inc (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- NorthStar Rx LLC (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- avenit AG (China)
- Ferring B.V. (Switzerland)
- Amring Pharmaceuticals Inc. (U.S.)
- Apotex Inc (Canada)
- Glenmark Pharmaceuticals Ltd (India)
- Mylan N.V. (U.S.)
SKU-